Capital and Enterprise Alliance Fashioned Between MEDIROM MOTHER Labs and NFES Applied sciences By Investing.com

TOKYO, Aug. 23, 2024 (GLOBE NEWSWIRE) — MEDIROM Healthcare Applied sciences Inc. (Headquarters: Minato-ku, Tokyo; CEO: Koji Eguchi; listed on Nasdaq, NASDAQ: MRM; hereinafter MEDIROM) broadcasts that its subsidiary MEDIROM MOTHER Labs Inc. (Headquarters: Minato-ku, Tokyo; CEO: Yoshio Uekusa; hereinafter MOTHER Labs), has fashioned a capital and enterprise alliance with NFES Applied sciences Inc. (Headquarters: Matsue Metropolis, Shimane Prefecture; CEO: Keita Adachi; hereinafter NFES Group), a subsidiary of NFES Inc. (Headquarters: Matsue Metropolis, Shimane Prefecture; CEO: Keita Adachi).

As a part of this alliance, NFES Group has agreed to take part because the lead investor in MOTHER Labs’ Sequence A financing spherical, which values MOTHER Labs at 9 billion yen on a pre-money foundation. The Sequence A shares shall be issued to NFES Group as a third-party allotment.

—¾ï¸Background of the Capital and Enterprise Alliance
The NFES Group is dedicated to making a world the place people can passionately pursue what they love. They resonate with MOTHER Labs’ dedication to international challenges as a Japanese firm and the idea behind the MOTHER Bracelet, a recharge-free good tracker designed to watch folks’s well being. This shared imaginative and prescient led to the capital and enterprise alliance, with the goal of collaborating with MOTHER Labs to advertise the MOTHER Bracelet and assist the well being of individuals worldwide.

—¾ï¸Future Initiatives
We’ve got concluded a distributorship settlement for MOTHER Bracelet, the recharge-free good tracker developed by the MEDIROM group, and MOTHER Gateway, MEDIROM’s telecommunication system which solely allows information generated by MOTHER Bracelet to be despatched to our proprietarily developed distant monitoring system, and can introduce these merchandise to firms within the nursing care, transportation, and manufacturing industries and promote their introduction by way of collaborations with monetary establishments and gross sales companions allied with NFES Group.

As well as, MOTHER Labs will even collaborate with Hyakkaten.com (a regional division retailer e-commerce mall operated by NFES Group) to conduct normal gross sales by way of shops and e-commerce websites nationwide.

With NFES Group collaborating because the lead investor on this Sequence A spherical, we anticipate attracting extra traders, permitting us to safe the mandatory funds for MOTHER Labs’ enterprise growth and facilitating the corporate’s additional enterprise improvement.

—¾ï¸Gross sales Construction
The NFES Group has established a brand new firm, NFES Applied sciences Inc., specializing in gross sales of MOTHER Bracelet and plans to increase gross sales each domestically and internationally because the designated major distributor of MOTHER Bracelet merchandise.

Ahead-Wanting Statements Relating to MEDIROM and MOTHER Labs

Sure statements on this press launch are forward-looking statements for functions of the secure harbor provisions beneath the U.S. Non-public Securities Litigation Reform Act of 1995. Ahead-looking statements could embody estimates or expectations about MEDIROM’s attainable or assumed operational outcomes, monetary situation, enterprise methods and plans, market alternatives, aggressive place, trade atmosphere, and potential progress alternatives. In some instances, forward-looking statements could be recognized by phrases akin to could, will, ought to, design, goal, goal, hope, count on, might, intend, plan, anticipate, estimate, consider, proceed, predict, undertaking, potential, purpose, or different phrases that convey the uncertainty of future occasions or outcomes. These statements relate to future occasions or to MEDIROM’s future monetary efficiency, and contain identified and unknown dangers, uncertainties and different elements that will trigger MEDIROM’s precise outcomes, ranges of exercise, efficiency, or achievements to be completely different from any future outcomes, ranges of exercise, efficiency or achievements expressed or implied by these forward-looking statements. You shouldn’t place undue reliance on forward-looking statements as a result of they contain identified and unknown dangers, uncertainties and different elements that are, in some instances, past MEDIROM’s management and which might, and certain will, have an effect on precise outcomes, ranges of exercise, efficiency or achievements. Any forward-looking assertion displays MEDIROM’s present views with respect to future occasions and is topic to those and different dangers, uncertainties and assumptions referring to MEDIROM’s operations, outcomes of operations, progress technique and liquidity. A number of the elements that might trigger precise outcomes to vary materially from these expressed or implied by the forward-looking statements on this press launch embody:

• MEDIROM’s potential to attain its improvement targets for its enterprise and execute and evolve its progress methods, priorities and initiatives;
• MEDIROM’s and NFES Group’s potential to collaborate within the anticipated method and on the anticipated phrases;
• MOTHER Labs’ potential to safe extra traders in its Sequence A financing spherical on acceptable phrases, or in any respect;
• adjustments in Japanese and international financial circumstances and monetary markets, together with their results on MEDIROM’s growth in Japan and sure abroad markets;
• MEDIROM’s potential to attain and maintain profitability in its Digital Preventative Healthcare

Section;

• the fluctuation of overseas trade charges, which impacts MEDIROM’s bills and liabilities payable in foreign exchange;
• MEDIROM’s potential to take care of and improve the worth of its manufacturers and to implement and preserve its emblems and defend its different mental property;
• MEDIROM’s potential to boost extra capital on acceptable phrases or in any respect;
• MEDIROM’s degree of indebtedness and potential restrictions on MEDIROM beneath MEDIROM’s debt devices;
• adjustments in shopper preferences and MEDIROM’s aggressive atmosphere;
• MEDIROM’s potential to answer pure disasters, akin to earthquakes and tsunamis, and to international pandemics, akin to COVID-19; and
• the regulatory atmosphere by which MEDIROM operates.

Extra info on these dangers and different potential elements that might have an effect on MEDIROM’s enterprise, status, outcomes of operations, monetary situation, and inventory worth is included in MEDIROM’s filings with the Securities and Alternate Fee (the SEC), together with within the Danger Elements and Working and Monetary Overview and Prospects sections of MEDIROM’s most not too long ago filed periodic report on Kind 20-F and subsequent filings, which can be found on the SEC web site at www.sec.gov. MEDIROM assumes no obligation to replace or revise these forward-looking statements for any cause, or to replace the explanations precise outcomes might differ from these anticipated in these forward-looking statements, even when new info turns into obtainable sooner or later.

– MEDIROM MOTHER Labs Inc.

MEDIROM MOTHER Labs Inc., a subsidiary of MEDIROM Healthcare Applied sciences Inc., primarily focuses on the well being tech sector. The corporate’s core actions embody the Particular Well being Steering Program supplied by way of the Lav well being software and improvement and gross sales of the 24/7 recharge-free MOTHER Bracelet good tracker. The tracker’s recognition raised a record-breaking 56.1 million yen on the Japanese crowdfunding platform Makuake. By leveraging the options of the recharge-free MOTHER Bracelet, MOTHER Labs presents customizable well being administration options throughout numerous sectors, together with caregiving, logistics, manufacturing, and many others.

・Firm Overview
Firm Title: MEDIROM MOTHER Labs Inc.
Headquarters: Tradepia Odaiba, 2-3-1 Daiba, Minato-ku, Tokyo
Consultant: Kouji Eguchi, Yoshio Uekusa
Institution: July 2023
Enterprise Space: Well being Tech Enterprise / Machine Enterprise / Software program Providers

– About MEDIROM Healthcare Applied sciences Inc.

・Firm Overview
Firm Title: MEDIROM Healthcare Applied sciences Inc.
Listed Market: NASDAQ
Ticker Image: MRM

Headquarters: Tradepia Odaiba, 2-3-1 Daiba, Minato-ku, Tokyo
CEO/Founder: Kouji Eguchi
Institution: July 2000
URL: https://medirom.co.jp/en

—¾ï¸About NFES Applied sciences Inc.

NFES Applied sciences Inc. is a well being tech firm established as a subsidiary of NFES Company, which develops artistic enterprise. The corporate will develop its enterprise centered on gross sales and system linkage of the MOTHER Bracelet good tracker, which requires no recharging 24 hours a day, 12 months a 12 months, and the MOTHER Gateway telecommunication system.

Firm identify: NFES Applied sciences, Inc.
Head Workplace: Shimane Financial institution Head Workplace Constructing 11F, 484-19 Asahi-cho, Matsue Metropolis, Shimane Prefecture
Consultant: Keita Adachi, CEO
Institution: July 2024
Enterprise: Well being tech enterprise
URL: https://nfes-tech.com

—¾ï¸About NFES Inc.

Firm identify: NFES Inc.
Head Workplace: Shimane Financial institution Head Workplace Bldg. 11F, 484-19 Asahi-cho, Matsue Metropolis, Shimane Prefecture
Consultant: Keita Adachi, CEO
Institution: Might 2022
Enterprise description: Artistic enterprise
URL: https://nfes.enjoyable

Contacts
Investor Relations Staff
ir@medirom.co.jp

Images accompanying this announcement can be found at

https://www.globenewswire.com/NewsRoom/AttachmentNg/733fb149-5951-4cd8-8eff-36a9480f8d75

https://www.globenewswire.com/NewsRoom/AttachmentNg/5208a192-b2b6-4eeb-9991-cd0bb357947f

https://www.globenewswire.com/NewsRoom/AttachmentNg/f4ab65e0-2b41-4982-90a1-5d9c19f4e9d5

https://www.globenewswire.com/NewsRoom/AttachmentNg/9e3433cd-4f86-4c26-bdc9-3cd916359712

https://www.globenewswire.com/NewsRoom/AttachmentNg/2fbe48d1-176e-40b4-a927-2652a4a14235

https://www.globenewswire.com/NewsRoom/AttachmentNg/4a44978d-ea5e-40d1-9e7b-0440f39791bb

Supply: MEDIROM Healthcare Applied sciences Inc.